Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Helixon
company
About
Helixon is a biotechnology company that accelerates novel drug discovery for unmet medical needs.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- ¥500M
- Industries
- Biotechnology,Medical
- Founded date
- Jul 1, 2021
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Huashen Zhiyao is a biotechnology company that accelerates novel drug discovery for unmet medical needs. Huashen Zhiyao develops an AI drug development platform and antibody engineering experiment platform to provide researchers with intelligent systems for microscopic molecular calculation, simulation, and design, committing to improving the speed and efficiency of new drug development.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥500M
Helixon has raised a total of
¥500M
in funding over 2 rounds. Their latest funding was raised on
Jun 22, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 22, 2022 | Series A | ¥500M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Helixon is funded by 1 investors.
Gaorong Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Gaorong Capital
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
